Prospects for the Future

@article{Gallo2002ProspectsFT,
  title={Prospects for the Future},
  author={R. Gallo and L. Montagnier},
  journal={Science},
  year={2002},
  volume={298},
  pages={1730 - 1731}
}
With close to 70 million people worldwide already infected with HIV and more than 20 million dead, AIDS has exacted and is continuing to exact a cruel toll on humanity. In the last of the four Viewpoints, Gallo and Montagnier look at the future prospects for controlling and eradicating AIDS worldwide. 
In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
TLDR
This review gives an overview of the disease and addresses the drugs currently used for treatment, with specific emphasis on new developments within the class of allosteric non-nucleoside reverse transcriptase inhibitors (NNRTIs). Expand
WHO, the Global Fund, and medical malpractice in malaria treatment
TLDR
Amir Attaran and colleagues highlight a very serious public-health issue: provision of ineffective drugs for a life-threatening disease is indefensible and the donors must take some responsibility for this failure. Expand
HIV postexposure prophylaxis in the 21st century.
  • D. Henderson
  • Biology, Medicine
  • Emerging infectious diseases
  • 2001
TLDR
The current state of knowledge in this field is described, substantive questions to be answered are identified, and basic principles of postexposure management are summarized. Expand
Reproductive Assistance in HIV-Serodiscordant Couples Where the Woman Is Positive
TLDR
The human immunodeficiency virus (HIV) is an RNA virus discovered at the beginning of the 1980s with a replicative cycle that can be divided into two phases: in the first phase the virus enters the cells, copies its RNA into a double-stranded DNA, and integrates this newly copied genome into the host cell. Expand
Cytopathic Mechanisms of HIV-1
  • J. Costin
  • Biology, Medicine
  • Virology Journal
  • 2007
TLDR
Information is gathered on TM in an attempt to shed some light on the functional regions of this protein, which is not well understood and is fiercely debated. Expand
Defects in the Adaptive Immune Response Leading to Recurrent Infections
TLDR
A report of recurrent and unusual infections in a group of homosexual males ushered in the realization that immunodeficiency could be acquired as a result of a viral infection in 1981. Expand
Evaluation of Reverse Transcriptase Assay for Viral Load Monitoring
TLDR
The RT assay documented in this thesis should be considered as a viable alternative for viral load monitoring, particularly in regions where expensive and complex gene-based technologies are not a viable option. Expand
Mitochondrial functionalism in HIV-infected children receiving antiretroviral therapy
TLDR
The main hypothesis of the present Thesis was to demonstrate that mitochondrial abnormalities are present in HIV-infected pediatric patients treated with ARV, and to elucidate whether ARV treatment or HIV infection were exerting a mitochondrial toxic effect in asymptomatic perinatally HIV- infected pediatric patients receiving HAART. Expand
Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
TLDR
It is demonstrated that these effects have to do primarily with solution phase interactions between the anti-HIV drugs, rather than from the drugs influencing each other's release rate, and it is suggested that such observations may indicate an important, previously inadequately recognized, and general phenomenon for ASDs containing multiple hydrophobic drugs. Expand
ANTAGONISTIC EVOLUTIONARY PATHWAYS OF HIV-1 RESISTANCE TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS: A VIROLOGICAL, BIOCHEMICAL AND CLINICAL INVESTIGATION
TLDR
It is proposed that K65R and TAMs represent two different pathways of NRTI resistance that exhibit bi-directional phenotypic antagonism and counterselection in vivo and will help to optimize current and future therapy for HIV-1 infection. Expand
...
1
2
3
4
5
...

References

SHOWING 1-9 OF 9 REFERENCES
HIV–1 neutralizing antibodies: How full is the bottle?
Potent neutralizing antibodies protect monkeys from SHIV challenge, but will vaccines ever be able to elicit antibody responses this powerful? (pages 204–216)
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
TLDR
Viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years. Expand
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent
TLDR
A mouse model in which SCID mice carry human peripheral blood leukocytes should prove useful for investigating cell-associated HIV-1 transmucosal HIV- 1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-2 transmission. Expand
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
TLDR
Nevirapine lowered the risk of HIV-1 transmission during the first 14-16 weeks of life by nearly 50% in a breastfeeding population, suggesting this simple and inexpensive regimen could decrease mother-to-child HIV- 1 transmission in less-developed countries. Expand
Synergistic Inhibition of HIV‐1 in Activated and Resting Peripheral Blood Mononuclear Cells, Monocyte‐Derived Macrophages, and Selected Drug‐Resistant Isolates With Nucleoside Analogues Combined With a Natural Product, Resveratrol
TLDR
It is reported that resveratrol (RV) synergistically enhances the anti‐HIV‐1 activity of the nucleoside analogues zidovudine (AZT), zalcitabine (ddC), and didanosine ( ddl), and when compared with hydroxyurea (HU), both 100 mM HU and 10 mM RV showed similar enhancement of ddI‐antiviral suppressive activity. Expand
Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.
TLDR
It is demonstrated that specific NRTI antiretroviral agents have different activity against HIV RT, depending on the state of cell cycle of the infected cell. Expand
Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
  • T. Fouts, Karla Godfrey, +5 authors R. Pal
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2002
TLDR
It is suggested that covalently crosslinked complexes of the HIV-1 surface envelope glycoprotein and CD4 elicit broadly neutralizing humoral responses that, in part, may be directed against a novel epitope(s) found on theAIDS envelope. Expand
Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity.
TLDR
Compound 1, which has a favorable pharmacokinetic profile in rodents and primates, excellent oral bioavailability, and potent antiviral activity against a wide range of primary HIV-1 isolates, is a potentially promising new candidate for treatment of HIV- 1 infection. Expand
HIV fusion and its inhibition.